• Omicron Arrives On the Scene

    KNX In Depth -

    Kartik Chandran, Ph.D., says there is much to learn about the new COVID-19 variant, omicron, including if it is more likely to cause severe disease or spread more easily that currently dominant variants. He notes the importance of vaccination and getting booster shots to protect against the virus. Dr. Chandran is professor of microbiology & immunology and the Harold and Muriel Block Scholar in Virology at Einstein. (Interview begins at 1:22)

  • Searching for a Fountain of Youth

    CBS News -

    Nir Barzilai, M.D., talks about his plans for a clinical trial to study metformin, a diabetes drug, to target age-related diseases and to extend both lifespan and health span. Dr. Barzilai is professor of medicine and of genetics, the Ingeborg and Ira Leon Rennert Chair in Aging Research and director of the Institute for Aging Research at Einstein, and an endocrinologist at Montefiore. (Interview begins at 2:45)

  • Booster May Up Antibodies in Patients With Cancer When Standard Dose Fails

    Medscape -

    Lauren Shapiro, M.D., and Astha Thakkar, M.B.B.S., discuss their study that found that most cancer patients who had no measurable immune response after being fully vaccinated for COVID-19 developed antibodies following a booster shot. Drs. Shapiro and Thakkar are third-year hematology/oncology fellows at Albert Einstein College of Medicine and Montefiore Medical Center.

    Additional Coverage includes UPI, U.S. News & World Report (via HealthDay), MedPage Today

Research Publications

Community Publications